Neurogenic Voice Disorders: Mechanisms, Pathophysiology, and Clinical Management
Laryngeal Mechanics and Intrinsic Musculature
Vocal Fold Configurations by Motor Task:
Inhalation: Abducted (open).
Exhalation: Minimally abducted (less open).
Voiceless Consonants: Partially open (paramedian position).
Voice Production: Adducted at midline.
High Pitch and Singing: Elongated midline closure.
Glottal Stops and Cough: Tightly closed.
Swallowing and Heavy Lifting: Complete sphincteric closure.
Primary Intrinsic Laryngeal Muscles:
Posterior Cricoarytenoid (PCA): Pulls the muscular process back to achieve vocal fold abduction.
Lateral Cricoarytenoid (LCA): Pulls the muscular process forward to achieve vocal fold adduction.
Transverse and Oblique Arytenoids: Draw arytenoid cartilages together to adduct vocal folds.
Thyroarytenoid (TA): Pulls the muscular process closer to the thyroid cartilage, facilitating adduction and relaxing vocal folds.
Cricothyroid (CT): Rocks the cricoid cartilage on the thyroid cartilage to tense and elongate the vocal folds for pitch elevation.
Aryepiglottic: Pulls the epiglottis downward to protect the airway during swallowing.

Peripheral Innervation and Nerve Lesions

Superior Laryngeal Nerve (SLN):
Internal Branch: Provides sensory and secretory innervation to the larynx at and above the true vocal folds.
External Branch: Provides exclusive motor innervation to the cricothyroid muscle.
Paresis / Paralysis: Manifests as laryngeal sensory deficit, pitch range loss, and diplophonia in unilateral presentations due to unequal vocal fold tension; frequently viral in etiology.
Recurrent Laryngeal Nerve (RLN):
Motor Supply: Supplies all intrinsic laryngeal muscles except the cricothyroid (PCA, LCA, TA, and interarytenoids).
Sensory Supply: Supplies sensory innervation to the subglottic region below the true vocal folds.
Paresis / Paralysis: Stem from surgical trauma, malignancies, intubation injury, or idiopathic causes. Manifests as adductor or abductor insufficiency, breathiness, stridor, dysphagia, and an ineffective bovine cough.
Surgical and Medical Management of Paralysis:
Temporary Augmentation: Vocal fold injection using Gelfoam or autologous fat.
Permanent Augmentation: Injection using Voxx (Teflon has been discontinued due to granuloma formation and migration).
Structural Interventions: Surgical medialisation via Ishiki or Gortex thyroplasty, and surgical re-innervation procedures combined with voice therapy.
Neuromuscular Systems and Dysarthrophonias
Central Nervous System (CNS / UMN) versus Peripheral Nervous System (PNS / LMN):
CNS (UMN): Cortical motor regions oversee voluntary voice; brainstem pattern generators control reflexive voice, swallowing, respiration, and coughing. Damage (e.g., stroke, traumatic brain injury, neurodegeneration) causes spasticity, ataxia/incoordination, and initiation deficits.
PNS (LMN): Vagus nerve branches (RLN and SLN) deliver motor impulses directly to laryngeal target muscles. Damage leads to flaccidity and loss of pitch control.
Clinical Dysarthrophonia Profiles:
Flaccid Dysarthria (LMN Deficit): Arises from RLN/SLN injury or Lateral Medullary Syndrome; characterized by breathiness, harshness, audible inspiration, and velopharyngeal incompetence.
Hyperkinetic Dysphonia (Extrapyramidal / UMN Deficit): Present in chorea and dystonia; manifests as strained-hoarse phonation, intermittent vocal fold hyperadduction, voice arrests, excessive loudness fluctuations, and involuntary articulatory movements.
Hypokinetic Dysarthrophonia (Parkinsonism): Characterized by reduced vocal loudness, breathiness, monopitch, monoloudness, and incomplete vocal fold closure. Reduced loudness and breathiness can serve as an early sign prior to other neurologic indicators.
Mixed Dysarthria (UMN and LMN Deficit): Characteristic of Amyotrophic Lateral Sclerosis (ALS / MND) and Multiple Sclerosis (MS); characterized by strained-strangled harshness, a wet or gurgly quality, low pitch, vocal flutter or rapid tremor on vowel prolongation, hypernasality, and lingual fasciculations/atrophy.
Spasmodic Dysphonia and Clinical Interventions
Pathophysiology and Epidemiology:
Classified as a task-specific focal dystonia of the laryngeal musculature involving aberrant sensorimotor interplay between the motor cortex and brainstem reflexes.
Global prevalence ranges from per people, with a female predominance and onset in middle age.
Gradual progression, with reaching maximum severity within months; report traumatic emotional events preceding onset.
Associated with other dystonias in of cases (cervical, limb, oromandibular) and a positive family history of dystonia in .
Subtypes:
Mixed Spasmodic Dysphonia (MSD): Accounts for of cases; highly associated with coexisting dystonias () and vocal tremor ().
Abductor Spasmodic Dysphonia (ABSD): Accounts for of cases; characterized by intermittent abductor spasms producing breathy voice breaks and sudden aphonia.
Adductor Spasmodic Dysphonia (ADSD): Accounts for of cases; characterized by intermittent hyperadductor spasms yielding a strained-strangled vocal quality, voice arrests, and phonation breaks.
Medical Treatments:
Botulinum Toxin (Botox) Injections: Treatment of choice.
ADSD Protocol: Injected bilaterally into the thyroarytenoid (TA) muscle (occasionally LCA and strap muscles) at an average of per vocal fold, achieving a success rate.
ABSD Protocol: Delivered unilaterally to the posterior cricoarytenoid (PCA) muscle at an average of , achieving a success rate.
Adverse Effects: Transient breathiness in (persisting ; worse in males) and transient dysphagia in (persisting ; worse in ABSD). Benefits persist for .
Pharmacological Trials: Longer-lasting DaxibotulinumtoxinA (Daxxify) and trials evaluating Sodium Oxybate.
Assessment and Behavioral Management:
Diagnostic Battery: Case history, acoustic and auditory-perceptual analysis, Voice-Related Quality of Life instruments, and standardized dysarthria protocols (e.g., Frenchay, Robertson).
Behavioral Interventions: Pre-medical voice therapy focused on vocal onset timing and laryngeal muscle relaxation, Lee Silverman Voice Treatment (LSVT LOUD), glottal efficiency drills, amplification, and surface electromyography (sEMG) biofeedback.